November 20, 2026
Source: drugdu
40

On November 19, Menovo disclosed that it had received a Certificate of Suitability to the monographs of the European Pharmacopoeia (CEP) for its venlafaxine hydrochloride API from the European Directorate for the Quality of Medicines & HealthCare (EDQM).
Source: http://finance.eastmoney.com/a/202611193935180661.html
By editoryour submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.